Submitted by Anonymous (not verified) on 5 February 2025 - 8:40
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 20, Status: Authorised